Heart Health Alert: Cardiac Risks for Women Under 50
Heart Health Alert: Cardiac Risks for Women Under 50
Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience
Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience
Phase 3 study results of plozasiran in patients with FCS
Phase 3 study results of plozasiran in patients with FCS
How Artificial Intelligence Can Add Precision in Peripartum Cardiovascular Medicine
How Artificial Intelligence Can Add Precision in Peripartum Cardiovascular Medicine
AI in Nuclear Medicine: Improvements in the Field
AI in Nuclear Medicine: Improvements in the Field
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Beyond the Horizon: HELIOS Clinical Trials in ATTR Cardiomyopathy
Beyond the Horizon: HELIOS Clinical Trials in ATTR Cardiomyopathy
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Promising results for self-expanding TAVR device in trial with mostly women
Promising results for self-expanding TAVR device in trial with mostly women
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Preventive PCI versus optimal medical therapy only for vulnerable plaques
